Fatima Soghra, Yaghini Fariborz A, Pavicevic Zoran, Kalyankrishna Shailaja, Jafari Nauzanene, Luong Elizabeth, Estes Anne, Malik Kafait U
Department of Pharmacology, College of Medicine, University of Tennessee Health Science Center, Memphis, 38163, USA.
J Pharmacol Exp Ther. 2005 Jun;313(3):1017-26. doi: 10.1124/jpet.104.081992. Epub 2005 Feb 10.
Cytosolic phospholipase A(2) (cPLA(2)) is activated and translocated to the nuclear envelope by various vasoactive agents, including norepinephrine (NE), and releases arachidonic acid (AA) from tissue phospholipids. We previously demonstrated that NE-induced cPLA(2) translocation to the nuclear envelope is mediated via its phosphorylation by calcium/calmodulin-dependent kinase-II in rabbit vascular smooth muscle cells (VSMCs). Cytoskeletal structures actin and microtubule filaments have been implicated in the trafficking of proteins to various cellular sites. This study was conducted to investigate the contribution of actin and microtubule filaments to cPLA(2) translocation to the nuclear envelope and its activation by NE in rabbit VSMCs. NE (10 microM) caused cPLA(2) translocation to the nuclear envelope as determined by immunofluorescence. Cytochalasin D (CD; 0.5 microM) and latrunculin A (LA; 0.5 microM) that disrupted actin filaments, blocked cPLA(2) translocation elicited by NE. On the other hand, disruption of microtubule filaments by 10 microM colchicine did not block NE-induced cPLA(2) translocation to the nuclear envelope. CD and LA did not inhibit NE-induced increase in cytosolic calcium and cPLA(2) activity, determined from the hydrolysis of l-1-[(14)C]arachidonyl phosphatidylcholine and release of AA. Coimmunoprecipitation studies showed an association of actin with cPLA(2), which was not altered by CD or LA. Far-Western analysis showed that cPLA(2) interacts directly with actin. Our data suggest that NE-induced cPLA(2) translocation to the nuclear envelope requires an intact actin but not microtubule filaments and that cPLA(2) phosphorylation and activation and AA release are independent of its translocation to the nuclear envelope in rabbit VSMCs.
胞质型磷脂酶A2(cPLA2)可被包括去甲肾上腺素(NE)在内的多种血管活性物质激活,并转位至核膜,从组织磷脂中释放花生四烯酸(AA)。我们之前证明,在兔血管平滑肌细胞(VSMC)中,NE诱导的cPLA2转位至核膜是通过钙/钙调蛋白依赖性激酶II使其磷酸化介导的。细胞骨架结构肌动蛋白和微管丝与蛋白质向细胞各个部位的运输有关。本研究旨在探讨肌动蛋白和微管丝在兔VSMC中对cPLA2转位至核膜及其被NE激活的作用。免疫荧光检测显示,NE(10微摩尔)可导致cPLA2转位至核膜。破坏肌动蛋白丝的细胞松弛素D(CD;0.5微摩尔)和拉春库林A(LA;0.5微摩尔)可阻断NE诱导产生的cPLA2转位。另一方面,10微摩尔秋水仙碱破坏微管丝并不阻断NE诱导的cPLA2转位至核膜。CD和LA并不抑制NE诱导的胞质钙增加及cPLA2活性,这是通过l-1-[(14)C]花生四烯酰磷脂酰胆碱的水解及AA的释放来测定的。免疫共沉淀研究显示肌动蛋白与cPLA2存在关联,且这种关联不受CD或LA影响。Far-Western分析表明cPLA2可直接与肌动蛋白相互作用。我们的数据表明,在兔VSMC中,NE诱导的cPLA2转位至核膜需要完整的肌动蛋白丝而非微管丝,且cPLA2的磷酸化、激活及AA释放与其转位至核膜无关。